Developer docs
API playgroundTry for free, no card

Search company profiles

hyggio

Full company profile

uuid000w3vr

Namestring
hyggio
Websiteurl
hyggio.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Hyggio is a Poland-based private company, founded in 2020 and headquartered in Katowice, that operates as a marketplace intended to accelerate clinical trials by connecting demand-side stakeholders (presumably trial sponsors, CROs, or research sites) with supply-side providers of digital solutions and medical expertise. The publicly stated value proposition is the merging of digital tooling with clinical-domain knowledge to compress trial execution timelines, but the company's own web property returned only a loading/verification page in the data scrape, so the specific product surface, transaction mechanics, and underlying technology stack are not documented in the source material.

The company is led by founder/CEO Patryk Ogórek, with Tomek Dabrowski serving as Chairman of the Executive Board. Headcount is reported in the 11–50 range, placing it firmly in the early-stage operating tier. No funding rounds, investors, partnership announcements, named customers, pricing model, product modules, patents, certifications, or geographic footprint details are present in the supplied data. Accordingly, the business model — whether commission-based, subscription, SaaS, or hybrid — cannot be confirmed from available evidence, and the company's actual commercial traction and revenue are undisclosed.

For an investment audience, the key takeaway is that hyggio's market positioning (clinical-trial acceleration marketplace) addresses a credible and growing pain point in the life-sciences R&D outsourcing stack, but the data set is unusually thin: almost every operational dimension beyond the name, tagline, founding year, location, and two-person leadership is blank. Diligence would need to source primary information directly from the company on products, pricing, pipeline, capital structure, and customer references before any commercial assessment could be made.

Short descriptiontext

Hyggio is a Poland-based marketplace founded in 2020 that connects clinical trial demand with digital solutions and medical expertise to accelerate trial execution, serving pharmaceutical sponsors, CROs, and research sites.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWarsaw, Poland
HQ citystring
Warsaw
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
clinical trial marketplace, clinical research services, medical expertise platform, digital health solutions, trial site matching
Industry2 codes
PRIMARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Marketplace
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

hyggio operates a marketplace that accelerates clinical trials by merging digital solutions with medical expertise. The platform connects stakeholders across the clinical research ecosystem to streamline the planning, recruitment, and execution of clinical studies. It is positioned as a digital intermediary that brings together technology and clinical know-how to reduce friction in trial operations.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Clinical Trial Marketplace Platform
CategoryClinical Trial Marketplace
Description

A digital marketplace that connects clinical trial stakeholders (such as sponsors, CROs, sites, investigators, and digital health solution providers) to accelerate the design, recruitment, and execution of clinical studies.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

ICON is a top global CRO providing site management, monitoring, and patient recruitment services, representing the incumbent benchmark against which any trial-acceleration marketplace must compete.

TypeBroad incumbent
Description

Medidata offers the industry-standard Rave EDC and clinical trial platform suite, an incumbent comparable to Hyggio's digital trial-acceleration technology.

TypeEmerging player
Description

TrialX operates a patient-trial matching and recruitment platform with a focus on health system integration, comparable to Hyggio's digital matchmaking layer for clinical trials.

TypeBroad incumbent
Description

IQVIA is the largest global CRO and clinical trial technology provider, offering overlapping site-management, feasibility, and trial-acceleration services that compete broadly with Hyggio.

TypeBroad incumbent
Description

Veeva provides the Veeva Vault CTMS and clinical data platform widely used by sponsors and CROs, representing an incumbent technology suite overlapping with Hyggio's digital-infrastructure layer.

6Deep 6 AI
TypeDirect peer
Description

Deep 6 AI uses AI to match patients to clinical trials and accelerate site feasibility, directly competitive with Hyggio's marketplace approach to trial acceleration.

7Mendel
TypeEmerging player
Description

Mendel applies AI to structure clinical trial documents and accelerate protocol-to-patient workflows, partially overlapping with Hyggio's digitization of clinical trial processes.

TypeDirect peer
Description

Castor provides a clinical trial technology platform for sites and sponsors, including eCRF, ePRO, and decentralized trial tools — overlapping with Hyggio's digital layer for clinical trial operations.

9Antidote (formerly TrialReach)
TypeDirect peer
Description

Antidote operates a digital marketplace matching patients and investigators to clinical trials, directly comparable to Hyggio's stated marketplace-plus-expertise model for accelerating trial recruitment.

TypeEmerging player
Description

Massive Bio runs an AI-driven oncology clinical trial enrollment marketplace, a niche but directly comparable marketplace model for matching patients and sites to trials.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

hyggio

Clinical Trial Marketplacehyggio.com

Hyggio is a Poland-based marketplace founded in 2020 that connects clinical trial demand with digital solutions and medical expertise to accelerate trial execution, serving pharmaceutical sponsors, CROs, and research sites.

What hyggio does

Hyggio is a Poland-based private company, founded in 2020 and headquartered in Katowice, that operates as a marketplace intended to accelerate clinical trials by connecting demand-side stakeholders (presumably trial sponsors, CROs, or research sites) with supply-side providers of digital solutions and medical expertise. The publicly stated value proposition is the merging of digital tooling with clinical-domain knowledge to compress trial execution timelines, but the company's own web property returned only a loading/verification page in the data scrape, so the specific product surface, transaction mechanics, and underlying technology stack are not documented in the source material.

The company is led by founder/CEO Patryk Ogórek, with Tomek Dabrowski serving as Chairman of the Executive Board. Headcount is reported in the 11–50 range, placing it firmly in the early-stage operating tier. No funding rounds, investors, partnership announcements, named customers, pricing model, product modules, patents, certifications, or geographic footprint details are present in the supplied data. Accordingly, the business model — whether commission-based, subscription, SaaS, or hybrid — cannot be confirmed from available evidence, and the company's actual commercial traction and revenue are undisclosed.

For an investment audience, the key takeaway is that hyggio's market positioning (clinical-trial acceleration marketplace) addresses a credible and growing pain point in the life-sciences R&D outsourcing stack, but the data set is unusually thin: almost every operational dimension beyond the name, tagline, founding year, location, and two-person leadership is blank. Diligence would need to source primary information directly from the company on products, pricing, pipeline, capital structure, and customer references before any commercial assessment could be made.

hyggio firmographics

Firmographics
Name
hyggio
Website
https://hyggio.com
Company type
Private
Founded year
2020
Headcount range
11–50 employees
Short description
Hyggio is a Poland-based marketplace founded in 2020 that connects clinical trial demand with digital solutions and medical expertise to accelerate trial execution, serving pharmaceutical sponsors, CROs, and research sites.
Ownership category
akta.pro rank

hyggio industry classification

Industry
Product category
Clinical Trial Marketplace
NAICS
Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination

Keywords

  • Clinical trial marketplace
  • Clinical research services
  • Medical expertise platform
  • Digital health solutions
  • Trial site matching

Where hyggio is headquartered

Location

Headquarters

HQ city
Warsaw
HQ country
Poland
HQ region
Europe

Markets served

hyggio business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

hyggio product offering

Product offering

Core offering

hyggio operates a marketplace that accelerates clinical trials by merging digital solutions with medical expertise. The platform connects stakeholders across the clinical research ecosystem to streamline the planning, recruitment, and execution of clinical studies. It is positioned as a digital intermediary that brings together technology and clinical know-how to reduce friction in trial operations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Marketplace Platform A digital marketplace that connects clinical trial stakeholders (such as sponsors, CROs, sites, investigators, and digital health solution providers) to accelerate the design, recruitment, and execution of clinical studies.

Companies that use hyggio

Customer profile

Ideal customer profiles1 record

hyggio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

hyggio partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

hyggio competitors and assessment

Company assessment

Broad incumbents

  • ICON plc: ICON is a top global CRO providing site management, monitoring, and patient recruitment services, representing the incumbent benchmark against which any trial-acceleration marketplace must compete.
  • Medidata (Dassault Systèmes): Medidata offers the industry-standard Rave EDC and clinical trial platform suite, an incumbent comparable to Hyggio's digital trial-acceleration technology.
  • IQVIA: IQVIA is the largest global CRO and clinical trial technology provider, offering overlapping site-management, feasibility, and trial-acceleration services that compete broadly with Hyggio.
  • Veeva Systems: Veeva provides the Veeva Vault CTMS and clinical data platform widely used by sponsors and CROs, representing an incumbent technology suite overlapping with Hyggio's digital-infrastructure layer.

Emerging players

  • TrialX: TrialX operates a patient-trial matching and recruitment platform with a focus on health system integration, comparable to Hyggio's digital matchmaking layer for clinical trials.
  • Mendel: Mendel applies AI to structure clinical trial documents and accelerate protocol-to-patient workflows, partially overlapping with Hyggio's digitization of clinical trial processes.
  • Massive Bio: Massive Bio runs an AI-driven oncology clinical trial enrollment marketplace, a niche but directly comparable marketplace model for matching patients and sites to trials.

Direct peers

  • Deep 6 AI: Deep 6 AI uses AI to match patients to clinical trials and accelerate site feasibility, directly competitive with Hyggio's marketplace approach to trial acceleration.
  • Castor: Castor provides a clinical trial technology platform for sites and sponsors, including eCRF, ePRO, and decentralized trial tools — overlapping with Hyggio's digital layer for clinical trial operations.
  • Antidote (formerly TrialReach): Antidote operates a digital marketplace matching patients and investigators to clinical trials, directly comparable to Hyggio's stated marketplace-plus-expertise model for accelerating trial recruitment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

hyggio social profiles

Digital presence

hyggio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

hyggio leadership team

Management profile

Number of profiles

Profiles2 records

hyggio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

hyggio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about hyggio

What does hyggio do?

hyggio operates a marketplace that accelerates clinical trials by merging digital solutions with medical expertise. The platform connects stakeholders across the clinical research ecosystem to streamline the planning, recruitment, and execution of clinical studies. It is positioned as a digital intermediary that brings together technology and clinical know-how to reduce friction in trial operations.

When was hyggio founded?

hyggio was founded in 2020. It employs 11 to 50 people.

Where is hyggio based?

hyggio is headquartered in Warsaw, Poland, in the Europe region.

Who are hyggio's main competitors?

Broad incumbents on record are ICON plc, Medidata (Dassault Systèmes), IQVIA and Veeva Systems. Emerging players are TrialX, Mendel and Massive Bio. Direct peers are Deep 6 AI, Castor and Antidote (formerly TrialReach).

Does hyggio have an API?

No public API is recorded for hyggio.

What industry is hyggio in?

hyggio's product category is Clinical Trial Marketplace. Its primary akta.pro industry code is HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 54151 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales